FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Top Story

Colorado researchers remove leukemia's shield, making it easier to kill

Acute myeloid leukemia is almost diabolically adaptable, able to resist chemotherapy and other formidable drug weapons doctors use to fight it. Read more...

Report

Johns Hopkins tapping genomes to find out why so many African-Americans get asthma

No one is sure why as many as 20% of African-Americans have asthma. Kathleen Barnes will lead an effort to solve the medical mystery. Barnes is an immunogeneticist at The Johns Hopkins University's School of Medicine and Bloomberg School of Public Health. She's the principal investigator of a recently launched, four-year plan to sequence the genomes of 1,000 people of African descent. Article

Also Noted

Stem Cell Research

> Adult stem cells helped build a better penis in rats, Science is reporting. Story

> Human embryonic stem cells developed by Advanced Cell Technology ($ACTC) helped improve vision in two patients, The New York Times reports. Story

Cancer

> A specific chromosomal abnormality has both prognostic and predictive value for managing the treatment of adult patients with a rare brain tumor, the Radiation Therapy Oncology Group has determined. Release

> Researchers at the Moffitt Cancer Center and the University of South Florida have discovered that interaction between a specific type of immune system cell and myeloid-derived suppressor cells inhibits some T-cell function. Release

Genetics

Read more >>